Funding Rounds
Affectis Pharmaceuticals

Affectis Pharmaceuticals Series D (2010, $0M)

Affectis Pharmaceuticals

Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $0.35M

Investors